analyse this test
ASO titre elevated ESR rheumatic disease elderly
antistreptolysin O ESR elevated interpretation
| Test | Result | Reference Range | Status |
|---|---|---|---|
| ASO Titre | 233 IU/ml | 0-200 IU/ml | ⚠️ HIGH |
| RA Factor | 5.7 IU/ml | Up to 20 IU/ml | ✅ Normal |
| ESR | 110 mm/hr | 3-10 mm/hr (lab range) | 🔴 Very High |
⚠️ Important: This analysis is for informational purposes only. These results must be interpreted by her treating physician (Dr. K.N. Prasobhithan) in the context of her full clinical history, symptoms, and physical examination. Do not start, stop, or change any medication based on lab results alone.
kaypen 250
Kaypen 250 amoxicillin tablet India uses dosage
https://www.1mg.com/drugs/kaypen-250-tablet-846279
Note: This is Penicillin V, not Amoxicillin. Penicillin V is more targeted (gram-positive bacteria only) while Amoxicillin is broader spectrum.
| Condition | Notes |
|---|---|
| Streptococcal throat infection (pharyngitis/tonsillitis) | First-line drug of choice |
| Ear infections (otitis media) | Mild/moderate cases |
| Nasal sinus infections | Gram-positive organisms |
| Respiratory tract infections | Pneumococcal pneumonia (mild) |
| Skin & soft tissue infections | Streptococcal cellulitis, erysipelas |
| Rheumatic fever - Treatment | Oral Penicillin V for 10 days to eradicate Group A Streptococcus (GAS) - Braunwald's Heart Disease |
| Rheumatic fever - Prevention (Prophylaxis) | Long-term prophylaxis to prevent recurrence - Goodman & Gilman's |
| Syphilis | Early stages |
| Guttate psoriasis | To eradicate streptococcal trigger |
| Patient | Dose | Frequency | Duration |
|---|---|---|---|
| Children <27 kg | 250 mg (400,000 U) | 2-3 times/day | 10 days |
| Adults / >27 kg | 500 mg (800,000 U) | 2-3 times/day | 10 days |
| Rheumatic fever prophylaxis | 250 mg | Every 12 hours | Long-term (years) |
| Penicillin allergy | Do NOT take if allergic to any penicillin. Tell your doctor. Cross-allergy with cephalosporins (~5-10%) |
| Pregnancy | Generally considered safe under doctor supervision |
| Bacterial endocarditis | NOT recommended for prophylaxis in patients with pre-existing heart valve disease |
| Infectious mononucleosis | Avoid ampicillin/amoxicillin (not Penicillin V) - may cause rash |
| Complete the course | Even if symptoms improve - stopping early risks relapse and antibiotic resistance |
⚠️ This information is for educational purposes. Always follow the prescribing doctor's exact instructions on dose and duration.
phenoxymethypenicillin potassium tablet
phenoxymethylpenicillin potassium tablet pharmacology uses dosage clinical
| Generic name | Phenoxymethylpenicillin Potassium |
| Also known as | Penicillin V Potassium (Penicillin VK) |
| Indian brand | Kaypen 250 (Hindustan Antibiotics Ltd) |
| Drug class | Natural (narrow-spectrum) Penicillin - Beta-lactam antibiotic |
| Available strengths | 125 mg, 250 mg, 500 mg tablets; liquids 125 mg/5ml & 250 mg/5ml |
| Feature | Penicillin G | Penicillin V (VK) |
|---|---|---|
| Route | Injection only | Oral tablet |
| Acid stability | Destroyed by stomach acid | Acid-stable |
| GI absorption | Poor orally | Good - plasma levels 2 to 5x higher than oral Pen G |
| Peak blood level | 15-30 min (IM) | 30-60 min (oral) |
| Condition | Role |
|---|---|
| Streptococcal pharyngitis / tonsillitis | First-line drug of choice |
| Rheumatic fever - treatment | 10-day course to eradicate Group A Streptococcus |
| Rheumatic fever - secondary prophylaxis | 250 mg twice daily, long-term - Harrison's Principles |
| Scarlet fever | Streptococcal eradication |
| Erysipelas / skin infections | Streptococcal cellulitis |
| Mild pneumococcal pneumonia | Outpatient treatment |
| Syphilis (early stage) | Treponema pallidum |
| Dental/ENT prophylaxis | Prevention of endocarditis in rheumatic heart disease |
| Sickle cell disease prophylaxis | Prevents pneumococcal infections in asplenic children |
| Guttate psoriasis | Eradication of streptococcal trigger |
| Age | Treatment Dose | Frequency |
|---|---|---|
| Infants (<1 yr) | 62.5 mg | Every 6 hours |
| 1-5 years | 125 mg | Every 6 hours |
| 6-11 years | 250 mg | Every 6 hours |
| >12 years | 500 mg | Every 6 hours |
| Parameter | Detail |
|---|---|
| Absorption | Rapid oral absorption; peak at 30-60 min |
| Food effect | Food reduces absorption - take on empty stomach |
| Protein binding | ~80% bound to albumin |
| Distribution | Widely distributed - liver, bile, kidney, joints, semen; poor CNS penetration |
| Half-life (t½) | ~30-60 minutes |
| Excretion | 60-90% excreted unchanged in urine (renal tubular secretion) |
| Renal impairment | Dose reduction needed if GFR <10 ml/min |
| Drug | Effect |
|---|---|
| Probenecid (gout drug) | Blocks renal tubular secretion of penicillin → increases & prolongs penicillin blood levels |
| Warfarin / anticoagulants | Penicillin may alter clotting - monitor INR |
| Oral contraceptives | Minor theoretical reduction in efficacy |
| Neomycin (oral) | Reduces absorption of Penicillin V |
| Methotrexate | Penicillin reduces methotrexate clearance → toxicity risk |
⚠️ Important: Always take this medicine exactly as prescribed by your doctor. Do not self-medicate or share antibiotics. This information is for educational reference only.
rheumatoid arthritis
"rheumatoid arthritis"[MeSH Terms] AND "treatment"[MeSH Terms]
"rheumatoid arthritis" management guidelines biologic DMARDs
systemic lupus erythematous